DocuSign, Inc. (NASDAQ:DOCU) Stake Boosted by Nomura Asset Management Co. Ltd.

Nomura Asset Management Co. Ltd. raised its holdings in shares of DocuSign, Inc. (NASDAQ:DOCU) by 20.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 179,453 shares of the company’s stock after purchasing an additional 30,859 shares during the period. Nomura Asset Management Co. Ltd. owned about 0.09% of DocuSign worth $16,140,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. State Street Corp raised its stake in DocuSign by 2.3% during the third quarter. State Street Corp now owns 5,372,939 shares of the company’s stock worth $333,604,000 after acquiring an additional 120,743 shares during the period. American Century Companies Inc. lifted its holdings in shares of DocuSign by 18.5% in the 4th quarter. American Century Companies Inc. now owns 5,315,459 shares of the company’s stock worth $478,072,000 after purchasing an additional 831,611 shares during the last quarter. Geode Capital Management LLC grew its stake in DocuSign by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 3,483,184 shares of the company’s stock worth $215,789,000 after buying an additional 53,554 shares during the last quarter. Norges Bank acquired a new stake in DocuSign in the fourth quarter worth $223,196,000. Finally, Thrivent Financial for Lutherans increased its position in DocuSign by 1.8% in the fourth quarter. Thrivent Financial for Lutherans now owns 2,318,137 shares of the company’s stock worth $208,494,000 after buying an additional 40,825 shares during the period. 77.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have recently commented on DOCU shares. Hsbc Global Res upgraded shares of DocuSign to a “moderate sell” rating in a research report on Friday, December 6th. JPMorgan Chase & Co. upgraded shares of DocuSign from an “underweight” rating to a “neutral” rating and upped their target price for the stock from $70.00 to $75.00 in a research report on Monday, March 10th. Wedbush reaffirmed a “neutral” rating and set a $100.00 price target on shares of DocuSign in a report on Friday, March 14th. JMP Securities reissued a “market outperform” rating and issued a $124.00 price objective on shares of DocuSign in a report on Tuesday, January 7th. Finally, Citigroup lifted their target price on DocuSign from $113.00 to $115.00 and gave the company a “buy” rating in a research note on Friday, March 14th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, DocuSign has a consensus rating of “Hold” and a consensus target price of $95.00.

Insider Buying and Selling

In related news, insider Robert Chatwani sold 15,706 shares of DocuSign stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $83.19, for a total value of $1,306,582.14. Following the transaction, the insider now owns 76,842 shares of the company’s stock, valued at approximately $6,392,485.98. This trade represents a 16.97 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $87.41, for a total transaction of $46,676.94. Following the sale, the director now directly owns 8,270 shares of the company’s stock, valued at $722,880.70. This represents a 6.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 97,851 shares of company stock worth $8,579,369 in the last three months. 1.66% of the stock is currently owned by insiders.

DocuSign Trading Down 2.9 %

Shares of DocuSign stock opened at $83.18 on Friday. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86. The stock has a market cap of $16.84 billion, a PE ratio of 17.15, a price-to-earnings-growth ratio of 6.94 and a beta of 1.02. The company’s 50-day moving average price is $87.18 and its two-hundred day moving average price is $81.36.

DocuSign (NASDAQ:DOCU) last released its earnings results on Thursday, March 13th. The company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.02. The business had revenue of $776.25 million for the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The business’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.76 EPS. On average, equities analysts predict that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.